Arndt Vogel, MD, PhD - Refining Treatment Models For Biliary Tract Cancer Aligning Practice With Rapidly Evolving Evidence on Immunotherapy and Targeted Platforms

This content has been developed for healthcare professionals only.
Patients who seek health information should consult with their
physician or relevant patient advocacy groups.

For the full presentation, downloadable Practice Aids, slides,
and complete CME/MOC/AAPA information, and to apply for credit,
please visit us at PeerView.com/VZA865. CME/MOC/AAPA credit will
be available until June 29, 2026.


Refining Treatment Models For Biliary Tract Cancer Aligning
Practice With Rapidly Evolving Evidence on Immunotherapy &
Targeted Platforms


In support of improving patient care, this activity has been
planned and implemented by PVI, PeerView Institute for Medical
Education, and Cholangiocarcinoma Foundation. PVI, PeerView
Institute for Medical Education, is jointly accredited by the
Accreditation Council for Continuing Medical Education (ACCME),
the Accreditation Council for Pharmacy Education (ACPE), and the
American Nurses Credentialing Center (ANCC), to provide
continuing education for the healthcare team.


SupportThis activity is supported by
independent medical education grants from Incyte Corporation,
Jazz Pharmaceuticals, Inc., Servier Pharmaceuticals LLC, and
Taiho Oncology, Inc.


Disclosure information is available at the beginning of the video
presentation.